While JNK activity is critical for tumor growth, excessive activation induced by miR-306 and miR-79 drives tumor elimination, highlighting RNF146 as a key modulator in JNK signaling and a potential target for miRNA-based cancer therapies [72]. This evidence concerns the gene MAPK8 and cancer.